Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04435808
What this trial is testing

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

Who this might be right for
COVID-19
University of New Mexico 1
Not applicableStudy completedNCT04468035
What this trial is testing

Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation

Who this might be right for
Covid19
Fondation Hôpital Saint-Joseph 22
Testing effectiveness (Phase 2)Study completedNCT04412668
What this trial is testing

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

Who this might be right for
SARS-CoV-2 (COVID-19) Severe Pneumonia
aTyr Pharma, Inc. 36
Not applicableUnknownNCT04779346
What this trial is testing

Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting

Who this might be right for
CancerCovid19Immunity
Universitätsklinikum Hamburg-Eppendorf 500
Not applicableStudy completedNCT04424446
What this trial is testing

Saliva as Source of Detection for SARS-CoV-2

Who this might be right for
COVID-19
National Institutes of Health Clinical Center (CC) 456
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Large-scale testing (Phase 3)Ended earlyNCT04802408
What this trial is testing

SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial

Who this might be right for
Covid19SARS-CoV Infection
Milton S. Hershey Medical Center 171
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Not applicableStudy completedNCT05643781
What this trial is testing

Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection

Who this might be right for
COVID-19TuberculosisPost-acute COVID-19 Syndrome
The Aurum Institute NPC 157
Not applicableStudy completedNCT04577235
What this trial is testing

Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.

Who this might be right for
COVID-19
Gaziosmanpasa Research and Education Hospital 29
Large-scale testing (Phase 3)Ended earlyNCT04329611
What this trial is testing

ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease

Who this might be right for
COVID-19
Dr. Michael Hill 148
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT04576728
What this trial is testing

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

Who this might be right for
Covid19
Biotest 166
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Not applicableStudy completedNCT04665960
What this trial is testing

Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

Who this might be right for
Covid19SARS-CoV InfectionSARS Pneumonia+2 more
NMC Specialty Hospital 35
Post-approval studies (Phase 4)Study completedNCT05049213
What this trial is testing

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19

Who this might be right for
Covid19SARS-CoV 2 Infection
National Taiwan University Hospital 7
Testing effectiveness (Phase 2)Study completedNCT04380961
What this trial is testing

Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

Who this might be right for
Critical Confirmed Coronavirus Disease (COVID)-19
Janssen Pharmaceutica N.V., Belgium 212
Not applicableUnknownNCT04345315
What this trial is testing

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Who this might be right for
COVID-19SARS-CoV-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500
Not applicableUnknownNCT04935450
What this trial is testing

Pulmonary Inflammation in COVID-19 ARDS

Who this might be right for
ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2COVID-19 Acute Respiratory Distress Syndrome
Hospital Universitario Ramon y Cajal 25
Not applicableStudy completedNCT04609462
What this trial is testing

High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.

Who this might be right for
Covid19Acute Hypoxemic Respiratory Failure
Fundacion Clinica Valle del Lili 199
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation